CA2385921A1 - Quinazolinones - Google Patents
Quinazolinones Download PDFInfo
- Publication number
- CA2385921A1 CA2385921A1 CA002385921A CA2385921A CA2385921A1 CA 2385921 A1 CA2385921 A1 CA 2385921A1 CA 002385921 A CA002385921 A CA 002385921A CA 2385921 A CA2385921 A CA 2385921A CA 2385921 A1 CA2385921 A1 CA 2385921A1
- Authority
- CA
- Canada
- Prior art keywords
- quinazolin
- formula
- phenyl
- formula ila
- absent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
- C07D239/90—Oxygen atoms with acyclic radicals attached in position 2 or 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
- C07D239/91—Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40795899A | 1999-09-28 | 1999-09-28 | |
US09/407,958 | 1999-09-28 | ||
PCT/EP2000/008940 WO2001023365A1 (en) | 1999-09-28 | 2000-09-13 | Quinazolinones |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2385921A1 true CA2385921A1 (en) | 2001-04-05 |
Family
ID=23614261
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002385921A Abandoned CA2385921A1 (en) | 1999-09-28 | 2000-09-13 | Quinazolinones |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1216235A1 (no) |
KR (1) | KR20020047186A (no) |
AR (1) | AR025797A1 (no) |
AU (1) | AU7654800A (no) |
BR (1) | BR0014294A (no) |
CA (1) | CA2385921A1 (no) |
NO (1) | NO20021502L (no) |
WO (1) | WO2001023365A1 (no) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7230000B1 (en) | 1999-10-27 | 2007-06-12 | Cytokinetics, Incorporated | Methods and compositions utilizing quinazolinones |
US7671200B2 (en) | 1999-10-27 | 2010-03-02 | Cytokinetics, Inc. | Quinazolinone KSP inhibitors |
US6545004B1 (en) | 1999-10-27 | 2003-04-08 | Cytokinetics, Inc. | Methods and compositions utilizing quinazolinones |
WO2003106435A1 (en) * | 2002-06-18 | 2003-12-24 | Sankyo Company, Limited | Fused-ring pyrimidin-4(3h)-one derivatives, processes for the preparation and uses thereof |
US20040152696A1 (en) * | 2002-08-01 | 2004-08-05 | Euro-Celtique S.A. | 2-substituted bicyclic benzoheterocyclic compounds and their use as sodium channel blockers |
WO2004041755A2 (en) * | 2002-11-04 | 2004-05-21 | Nps Pharmaceuticals, Inc. | Quinazolinone compounds as calcilytics |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1670416A1 (de) * | 1966-12-30 | 1971-02-11 | Chem Fab Von Heyden Gmbh Muenc | Verfahren zur Herstellung von aminosubstituierten Chinazolinonderivaten |
JPS6136273A (ja) * | 1984-07-26 | 1986-02-20 | Mitsubishi Yuka Yakuhin Kk | 2−フエニルアルキル−4(3h)−キナゾリノン誘導体 |
DE69521500T2 (de) * | 1994-03-08 | 2001-12-13 | Otsuka Pharma Co Ltd | Phosphorsäurediester-derivate |
US5783577A (en) * | 1995-09-15 | 1998-07-21 | Trega Biosciences, Inc. | Synthesis of quinazolinone libraries and derivatives thereof |
-
2000
- 2000-09-13 BR BR0014294-8A patent/BR0014294A/pt not_active Application Discontinuation
- 2000-09-13 WO PCT/EP2000/008940 patent/WO2001023365A1/en not_active Application Discontinuation
- 2000-09-13 AU AU76548/00A patent/AU7654800A/en not_active Abandoned
- 2000-09-13 KR KR1020027003907A patent/KR20020047186A/ko not_active Application Discontinuation
- 2000-09-13 CA CA002385921A patent/CA2385921A1/en not_active Abandoned
- 2000-09-13 EP EP00965991A patent/EP1216235A1/en not_active Withdrawn
- 2000-09-27 AR ARP000105076A patent/AR025797A1/es unknown
-
2002
- 2002-03-26 NO NO20021502A patent/NO20021502L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AR025797A1 (es) | 2002-12-11 |
KR20020047186A (ko) | 2002-06-21 |
NO20021502D0 (no) | 2002-03-26 |
WO2001023365A1 (en) | 2001-04-05 |
NO20021502L (no) | 2002-03-26 |
EP1216235A1 (en) | 2002-06-26 |
AU7654800A (en) | 2001-04-30 |
BR0014294A (pt) | 2002-05-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001293817A1 (en) | 4-amino-quinazolines | |
CA2385918A1 (en) | Quinazolinones | |
US20030004158A1 (en) | Nitrogen containing heterocyclic quinoline compounds | |
JPH07267926A (ja) | 4−アミノ−1−ピペリジルベンゾイルグアニジン | |
NZ318926A (en) | Alpha v beta 3 integrin (vitronectin) inhibitors or anatagonists derived from benzoic acid for treating diseases of cell adhesion | |
SK282480B6 (sk) | Derivát arylalkanoylpyridazínu, spôsob jeho prípravy, jeho použitie a farmaceutický prostriedok, ktorý ho obsahuje | |
US20040044204A1 (en) | 4-amino-quinazolines | |
CA2385921A1 (en) | Quinazolinones | |
EP1133475A1 (en) | Substituted benzo de]isoquinoline-1,3-diones | |
EP1144381A2 (en) | Substituted benzo[de]isoquinoline-1,3-diones | |
EP1343764B1 (en) | Urea and urethane derivatives as integrin inhibitors | |
SK11732001A3 (sk) | Deriváty beta-alanínu | |
US6890930B1 (en) | Quinazolinones | |
KR20040065233A (ko) | 2-구아니디노-4-헤테로사이클일퀴나졸린 | |
US7060706B1 (en) | Quinazolinones | |
SK192002A3 (en) | Diacylhydrazine derivatives, process for the preparation and use thereof and pharmaceutical composition comprising same | |
US7829566B2 (en) | 4-amino-quinazolines | |
SK12296A3 (en) | Derivatives of 4-aminobenzoylguanidine, substituted at ortho-position, preparation method thereof and pharmaceutical compositions containing them | |
MXPA01010294A (es) | Derivados de dibenzoazuleno para el tratamiento de la trombosis, osteoporosis, arteriosclerosis. | |
US20030187289A1 (en) | Biphenyl derivatives and the use thereof as integrin inhibitors | |
CZ2002298A3 (cs) | Derivát fluorenu, způsob jeho přípravy, jeho pouľití a farmaceutický prostředek, který ho obsahuje |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued |